Wells Fargo & Company Lowers Aflac (NYSE:AFL) Price Target to $102.00

Aflac (NYSE:AFL) had its price target decreased by equities research analysts at Wells Fargo & Company from $104.00 to $102.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The brokerage presently has an “equal weight” rating on the financial services provider’s stock. Wells Fargo & Company‘s target price indicates a potential downside of 2.21% from the stock’s current price.

A number of other research analysts also recently commented on AFL. BMO Capital Markets began coverage on Aflac in a report on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price target for the company. JPMorgan Chase & Co. upped their price objective on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Truist Financial upped their price objective on Aflac from $100.00 to $105.00 and gave the company a “hold” rating in a research note on Friday, November 1st. Finally, Barclays cut their price objective on Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, February 7th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $102.86.

Aflac Trading Down 0.2 %

Shares of AFL opened at $104.31 on Wednesday. The company has a market capitalization of $57.95 billion, a P/E ratio of 10.87, a P/E/G ratio of 3.30 and a beta of 0.99. Aflac has a one year low of $78.60 and a one year high of $115.50. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. The stock has a 50-day moving average price of $104.16 and a 200 day moving average price of $107.26.

Aflac (NYSE:AFL) last issued its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. Sell-side analysts forecast that Aflac will post 6.88 EPS for the current fiscal year.

Insider Activity at Aflac

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction on Friday, December 27th. The stock was sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at approximately $23,018,701.20. This trade represents a 10.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 0.90% of the stock is owned by insiders.

Hedge Funds Weigh In On Aflac

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Whipplewood Advisors LLC bought a new position in Aflac during the 4th quarter valued at $26,000. Darwin Wealth Management LLC bought a new position in Aflac during the 3rd quarter valued at $34,000. BankPlus Trust Department bought a new position in Aflac during the 4th quarter valued at $34,000. Curio Wealth LLC bought a new position in Aflac during the 4th quarter valued at $36,000. Finally, Raelipskie Partnership bought a new position in Aflac during the 3rd quarter valued at $38,000. 67.44% of the stock is owned by institutional investors.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.